Trials / Conditions / Arrhythmogenic Cardiomyopathy

Arrhythmogenic Cardiomyopathy

12 registered clinical trials studyying Arrhythmogenic Cardiomyopathy — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic NCT07050160	Lexeo Therapeutics	—
Recruiting	Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH) NCT06922994	Centro Cardiologico Monzino	Phase 2
Recruiting	Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy NCT06174220	Hamilton Health Sciences Corporation	Phase 2
Recruiting	Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy NCT06730464	Centro Medico Teknon	—
Recruiting	Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy NCT06352307	First Affiliated Hospital Xi'an Jiaotong University	—
Suspended	IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy NCT06275893	Implicit Bioscience	Phase 1 / Phase 2
Active Not Recruiting	Gene Therapy for ACM Due to a PKP2 Pathogenic Variant NCT06109181	Lexeo Therapeutics	Phase 1 / Phase 2
Recruiting	A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-AC NCT06976606	Lexeo Therapeutics	—
Recruiting	Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transpla NCT06813443	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Not Yet Recruiting	Diagnostic Contribution, Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy. (ACORE) NCT05569356	Assistance Publique - Hôpitaux de Paris	—
Unknown	South Asian Arrhythmogenic Cardiomyopathy Registry NCT04895540	Sheri Kashmir Institute of Medical Sciences	—
Recruiting	The Application of T1 Mapping in Real-World NCT07354646	Chinese Academy of Medical Sciences, Fuwai Hospital	—